Dividends Calendar Earnings Calendar

ALT | Altimmune Inc

Altimmune Inc

Company profile

  • Industry: Exchange Traded Fund
  • Sector: Financials
  • Headquarters:   Gaithersburg, Maryland, United States
  • Number of employees::   43

Company profile

Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell?, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B.

  • Subsidiaries:   Spitfire Pharma, LLC, PharmAthene UK Limited, Pharmathene US Corporation


910 Clopper Road
Suite 201S
Gaithersburg, MD 20878
United States

    Key Persons / Board of Directors

    • Chairman :  Chairperson: Mitchel B. Sayare Ph.D.
    • CEO :  Vipin K. Garg
    • CFO :  Will Brown

    Videos about Altimmune Inc

    Jump to (Finance sites)


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.

    BUY 88
    HOLD 13
    SELL 0

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 

    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.